$0.44
0.86%
Nasdaq, Fri, Dec 27 2024
ISIN
US74319F1075
Symbol
PROG

Progenity Inc Stock price

$0.44
-1.49 77.20% 1M
-6.01 93.17% 6M
-13.06 96.74% YTD
-12.86 96.69% 1Y
-499.56 99.91% 3Y
-3,279.56 99.99% 5Y
-3,279.56 99.99% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
-0.00 0.86%
ISIN
US74319F1075
Symbol
PROG
Sector

Key metrics

Market capitalization $1.99m
Enterprise Value $38.44m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 43.19
P/S ratio (TTM) P/S ratio 2.24
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 4,855.56%
Revenue (TTM) Revenue $890.00k
EBIT (operating result TTM) EBIT $-60.87m
Free Cash Flow (TTM) Free Cash Flow $-46.20m
Cash position $3.20m
EPS (TTM) EPS $-13.03
P/S forward 1.81
EV/Sales forward 34.95
Short interest 14.04%
Show more

Is Progenity Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Progenity Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Progenity Inc:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Progenity Inc:

Buy
100%

Financial data from Progenity Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
0.89 0.89
4,350% 4,350%
100%
- Direct Costs 0.44 0.44
27% 27%
49%
0.45 0.45
178% 178%
51%
- Selling and Administrative Expenses 34 34
7% 7%
3,870%
- Research and Development Expense 26 26
10% 10%
2,971%
-60 -60
10% 10%
-6,790%
- Depreciation and Amortization 0.44 0.44
27% 27%
49%
EBIT (Operating Income) EBIT -61 -61
10% 10%
-6,840%
Net Profit -32 -32
74% 74%
-3,544%

In millions USD.

Don't miss a Thing! We will send you all news about Progenity Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Progenity, Inc., a biotechnology company, provides complex molecular and specialized testing services to physicians, clinicians, and their patients in the United States. It offers testing services for common hereditary disorders, cystic fibrosis, spinal muscular atrophy, fragile X syndrome, and Jewish genetic diseases; pan-ethnic carrier screening services; non-invasive prenatal, miscarriage, and pharmacogenetic testing services; and ovarian assessment reports for women. The company also provides pediatric testing services. Progenity, Inc. was formerly known as Ascendant MDX, Inc. and changed its name to Progenity, Inc. in November, 2013. The company was incorporated in 2012 and is based in San Diego, California with a laboratory in Ann Arbor, Michigan. It has a bill payment location in Detroit, Michigan.

Head office United States
CEO Adi Mohanty
Employees 58
Founded 2010
Website www.bioratherapeutics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today